223 related articles for article (PubMed ID: 30452083)
1. Incremental clinical utility of continuous performance tests in childhood ADHD - an evidence-based assessment approach.
Tallberg P; Råstam M; Wenhov L; Eliasson G; Gustafsson P
Scand J Psychol; 2019 Feb; 60(1):26-35. PubMed ID: 30452083
[TBL] [Abstract][Full Text] [Related]
2. Behavioral Assessment of Core ADHD Symptoms Using the QbTest.
Reh V; Schmidt M; Lam L; Schimmelmann BG; Hebebrand J; Rief W; Christiansen H
J Atten Disord; 2015 Dec; 19(12):1034-45. PubMed ID: 23382579
[TBL] [Abstract][Full Text] [Related]
3. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
Hall CL; James M; Brown S; Martin JL; Brown N; Selby K; Clarke J; Vijayan H; Guo B; Sayal K; Hollis C; Groom MJ
BMJ Open; 2018 Feb; 8(2):e021104. PubMed ID: 29453304
[TBL] [Abstract][Full Text] [Related]
4. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial.
Hall CL; Walker GM; Valentine AZ; Guo B; Kaylor-Hughes C; James M; Daley D; Sayal K; Hollis C
BMJ Open; 2014 Dec; 4(12):e006838. PubMed ID: 25448628
[TBL] [Abstract][Full Text] [Related]
5. Does the Conners' Continuous Performance Test aid in ADHD diagnosis?
McGee RA; Clark SE; Symons DK
J Abnorm Child Psychol; 2000 Oct; 28(5):415-24. PubMed ID: 11100916
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
Najib J
Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
[TBL] [Abstract][Full Text] [Related]
7. ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents.
Stevanovic D; Wentz E; Nasic S; Knez R
BMC Psychiatry; 2022 Apr; 22(1):282. PubMed ID: 35448977
[TBL] [Abstract][Full Text] [Related]
8. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
9. The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures.
Faraone SV; Newcorn JH; Antshel KM; Adler L; Roots K; Heller M
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):672-685. PubMed ID: 27105181
[TBL] [Abstract][Full Text] [Related]
10. AULA virtual reality test as an attention measure: convergent validity with Conners' Continuous Performance Test.
Díaz-Orueta U; Garcia-López C; Crespo-Eguílaz N; Sánchez-Carpintero R; Climent G; Narbona J
Child Neuropsychol; 2014; 20(3):328-42. PubMed ID: 23638628
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
[TBL] [Abstract][Full Text] [Related]
12. Objective QbTest and subjective evaluation of stimulant treatment in adult attention deficit-hyperactivity disorder.
Bijlenga D; Jasperse M; Gehlhaar SK; Sandra Kooij JJ
Eur Psychiatry; 2015 Jan; 30(1):179-85. PubMed ID: 25172155
[TBL] [Abstract][Full Text] [Related]
13. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
Wang LJ; Chen CK; Huang YS
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):501-8. PubMed ID: 26262904
[TBL] [Abstract][Full Text] [Related]
14. Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach.
Hall CL; Valentine AZ; Walker GM; Ball HM; Cogger H; Daley D; Groom MJ; Sayal K; Hollis C
BMC Psychiatry; 2017 Feb; 17(1):66. PubMed ID: 28183284
[TBL] [Abstract][Full Text] [Related]
15. Monitoring medication response in ADHD: what can continuous performance tests tell us?
Cedergren K; Östlund S; Åsberg Johnels J; Billstedt E; Johnson M
Eur Arch Psychiatry Clin Neurosci; 2022 Mar; 272(2):291-299. PubMed ID: 34420075
[TBL] [Abstract][Full Text] [Related]
16. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
17. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
Biederman J; Swanson JM; Wigal SB; Boellner SW; Earl CQ; Lopez FA;
J Clin Psychiatry; 2006 May; 67(5):727-35. PubMed ID: 16841622
[TBL] [Abstract][Full Text] [Related]
18. The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial.
Hollis C; Hall CL; Guo B; James M; Boadu J; Groom MJ; Brown N; Kaylor-Hughes C; Moldavsky M; Valentine AZ; Walker GM; Daley D; Sayal K; Morriss R;
J Child Psychol Psychiatry; 2018 Dec; 59(12):1298-1308. PubMed ID: 29700813
[TBL] [Abstract][Full Text] [Related]
19. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
Efron D; Jarman F; Barker M
Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
